Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Tong Ren Tang Technologies Co's Revenue for the
six
months ended in Dec. 2025 was €332.9 Mil. Tong Ren Tang Technologies Co's average Accounts Receivable for the
six
months ended in Dec. 2025 was €104.7 Mil.
Hence, Tong Ren Tang Technologies Co's Receivables Turnover for the
six
months ended in Dec. 2025 was 3.18.
Tong Ren Tang Technologies Co (FRA:TNG) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Tong Ren Tang Technologies Co Receivables Turnover Related Terms
Tong Ren Tang Technologies Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tong Ren Tang Technologies Co Receivables Turnover Chart
FRA:TNG vs LLY, JNJ, ABBV: Receivables Turnover Comparison
For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tong Ren Tang Technologies Co Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Tong Ren Tang Technologies Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tong Ren Tang Technologies Co (FRA:TNG) has a Receivables Turnover of 3.18 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Tong Ren Tang Technologies Co and its competitors. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #233 out of 948 companies in the Drug Manufacturers industry, placing it in the top 24.6%.
Is Tong Ren Tang Technologies Co's Receivables Turnover too high?
Tong Ren Tang Technologies Co's current Receivables Turnover is 3.18. The Drug Manufacturers industry median Receivables Turnover is 5.07. Tong Ren Tang Technologies Co's value of 3.18 is 37.3% below this industry median. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #233 out of 948 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's Receivables Turnover compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #233 out of 948 companies for Receivables Turnover. This places Tong Ren Tang Technologies Co in the top 25% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Tong Ren Tang Technologies Co's value of 3.18 is 37.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 948 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tong Ren Tang Technologies Co's current Receivables Turnover of 3.18 is 37.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current Receivables Turnover is 3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Tong Ren Tang Technologies Co (FRA:TNG) has a current Receivables Turnover of 3.18. The stock's GF Value™ is €0.52, compared to a current price of €0.32 — trading 39.2% below its estimated fair value. The current Receivables Turnover is 3.18 and 37.3% below the Drug Manufacturers industry median of 5.07. Tong Ren Tang Technologies Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (FRA:TNG), the current Receivables Turnover is 3.18 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tong Ren Tang Technologies Co (FRA:TNG) Overvalued in 2026?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued.
The current stock price of €0.32 is trading 39.2% below its estimated GF Value™ of €0.52.
Key valuation signals for FRA:TNG:
Receivables Turnover: 3.18
GF Value™: €0.52 vs. price of €0.32 (39.2% below fair value)
Industry Position: 37.3% below the Drug Manufacturers median (#233 of 948)
No single metric tells the full story. See the FRA:TNG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
78GF Score
Get the complete analysis for FRA:TNG
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TNG has been successfully added to your 
